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Abstract: Gallic acid (3,4,5-trihydroxybenzoic acid, GA) is a plant secondary metabolite, which
shows antioxidant activity and is commonly found in many plant-based foods and beverages.
Recent evidence suggests that oxidative stress contributes to the development of many human
chronic diseases, including cardiovascular and neurodegenerative pathologies, metabolic syndrome,
type 2 diabetes and cancer. GA and its derivative, methyl-3-O-methyl gallate (M3OMG), possess
physiological and pharmacological activities closely related to their antioxidant properties. This paper
describes the antidepressive-like effects of intraperitoneal administration of GA and two synthetic
analogues, M3OMG and P3OMG (propyl-3-O-methylgallate), in balb/c mice with post-stroke
depression, a secondary form of depression that could be due to oxidative stress occurring during
cerebral ischemia and the following reperfusion. Moreover, this study determined the in vivo
antioxidant activity of these compounds through the evaluation of superoxide dismutase (SOD)
and catalase (Cat) activity, thiobarbituric acid-reactive substances (TBARS) and reduced glutathione
(GSH) levels in mouse brain. GA and its synthetic analogues were found to be active (at doses of
25 and 50 mg/kg) in the modulation of depressive symptoms and the reduction of oxidative stress,
restoring normal behavior and, at least in part, antioxidant endogenous defenses, with M3OMG
being the most active of these compounds. SOD, TBARS, and GSH all showed strong correlation with
behavioral parameters, suggesting that oxidative stress is tightly linked to the pathological processes
involved in stroke and PSD. As a whole, the obtained results show that the administration of GA,
M3OMG and P3OMG induce a reduction in depressive symptoms and oxidative stress.
Keywords: depression; gallic acid; ischemia; stroke
1. Introduction
Gallic acid (3,4,5-trihydroxybenzoic acid, GA, Figure 1A) is a secondary metabolite of plants,
mainly formed from 3-dehydroshikimic acid through the shikimic acid pathway occurring in all
plants. Thus, it is found in a wide array of foods in varying amounts according to plant species and
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environmental factors [1]. The main dietary sources of GA are red fruits (i.e., raspberries, blueberries,
and strawberries), grapes (Vitis vinifera L. and Vitis aestivalis Michx.), wine, oak bark, and gallnuts.
Many plant-based foods and beverages contain GA in its esterified form and/or as GA derivatives,
such as hydrolysable tannins, in addition to its free form. Green and semi-fermented or fermented
teas are the most important sources of GA in the esterified forms of catechin and epicatechin, while
gallotannins are not widespread in nature but have been identified in mango (Mangifera indica L.) and
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plants. Thus, it is found in a wide array of foods in varying amounts according to plant species and 
                     f i  (i. ., r i ,  l i , 
                  . ,  i ,    ,    ll ts. 
  ‐              i   st ifi  f r  a / r      , 
               f  f r .      ‐      
                    fi              
                  fi              
          . 
 











shows  antioxidant  activity when  compared with  GA, without  showing  prooxidant  activity  [8]. 
Further  investigations  on  the  in  vivo  antioxidant  properties  of  M3OMG  have  shown  that  this 
compound  is  able  to  exert  neuroprotective  and  cardioprotective  effects  against  NaF‐induced 
oxidative stress  in rat brains and  in erythrocyte hemolysates, respectively [9,10]. At the molecular 
level, GA and M3OMG exert their protective activities through different mechanisms of action. In 
peripheral  blood  mononuclear  cells  and  EVC‐304  cells,  M3OMG  acts  through  the  epigenetic 
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Figure 1. Chemical structure of gallic acid (A); methyl-3-O-methylgallate (B); and
propyl-3-O-methylgallate (C).
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s s antioxidant activity when compared with GA, without showing prooxidant activity [8]. Further
investigations on the in vivo antioxidant properties of M3OMG have shown that this compound is able
t exert europrotective and cardioprotective effects ag inst NaF-induced oxidative stress in rat brains
and in erythrocyte hemolysates, resp ctively [9,10]. At the mol cular level, GA and M3OMG exert
their protective activities through differ nt mechanisms of action. In p ripheral blood mononuclear
c lls and EVC-304 cells, M3OMG acts through the epigenetic regulation of t e expression levels of
miR-17-3p, a microRNA linked to the regulation of cellular redox status [11]. Furthermore, in different
prostate cancer cell subpopulatio s GA and M3OMG inhibit NF-kB transcriptional factor, a protein
complex that controls transcription of DNA, cyt kine production and cell survival [12].
Stroke is an acute cerebrovascular event caused by a reduction in the blood supplied to the brain,
resulting in br in cells death. Two main types of stroke are recognized: ischemic and hemorrhagic ones.
In an ischemic stroke the reduction of blood supplied to the brain is caused mainly by thromb sis due
to the formation of a local blood clot causing vessels occlusion, or by em olisms due to the presence
of an embolus elsewhere in the body, or y systemic hypoperfusion. The main consequences are
l cal hypoxia, ATP decrease, and intracellular calcium increase, leading to irreversible cells da age.
On the other hand, hemorrhagic stroke occurs when a weakened blood vessel ruptures. Two main
types of weakene blood vessels are at the basis of hemorrhagic stroke: aneurysm and arterioven us
abnormalities, both causing bleeding into the brain after rupture. Stroke represents the second leading
cause of disability in Europe and the sixth leading cause worl wide [13]. Five minutes after the onset
of ischemic stroke, neurons begin to die due to oxygen and glucose deprivation, which leads to a
series of negative mechanisms resulting in damage to the brain tissue. These mecha isms include
oxidative stress, mitochondrial dysfunction, neuroinflam ation, activation of glutamate receptors,
and reduction of circulating levels of nitric oxide [14,15].
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Among the complications of ischemic stroke, post-stroke depression (PSD) has high clinical
relevance. One third of patients experience depression within the first year after the onset of stroke,
which persists for over 20 months in 34% of elderly patients with acute stroke [16]. PSD is linked
to worsened cognitive and physical outcomes, since it delays the recovery process and reduces the
effect of therapy and rehabilitation. Morbidity and mortality are highly increased as a consequence.
The common therapeutic approach for PSD consists of antidepressant pharmacotherapy, which is
effective in increasing the number of patients reaching partial or full independence. Nevertheless,
antidepressant drugs can cause side and adverse effects serious enough to make patients stop taking
the medication, thus aggravating morbidity [16].
The World Health Organization reports that low fruit and vegetable intake is among the six
main risk factors for cardiovascular diseases (with high blood pressure, high blood glucose, physical
inactivity, overweight and obesity). Moreover, an insufficient intake of fruit and vegetables is estimated
to contribute to around 9% of stroke deaths worldwide [17]. In addition, there is substantial evidence
regarding the role of oxidative stress in the pathogenesis of both ischemic stroke and depression. Thus,
our research group postulated the hypothesis that polyphenols and vegetable foods could have a
potential therapeutic role in PSD due to their antioxidant activity [18]. Our previous research highlights
the in vivo cardio- and neuroprotective effects of GA and its derivatives against oxidative stress [9,10,
19,20]. Moreover, the benefits of GA on the brain and cognitive functions are well documented. In fact,
GA reduces chronic cerebral hypoperfusion in rats and has a significant protective effect on brain cell
viability [21]. In addition, GA shows antidepressive-like activity in a mouse model of unpredictable
chronic mild stress [22]. A further study confirms this property by treating mice with GA brain targeted
nanoparticles, which are able to improve both its antioxidant and antidepressant-like activity [23].
The antidepressive-like activity of GA has not been explored in a mouse model of PSD to date, and
in view of this, the first aim of the present paper is to study the antidepressive-like effects exerted by
intraperitoneal administration of GA in balb/c mice with post-stroke depression. Recent investigations
into the protective effects of polyphenols have been accompanied by an increasing evaluation of their
synthetic and semisynthetic analogues, which can ameliorate the bioavailability and the metabolic
conversion of the original natural product, whilst maintaining both efficacy and low toxicity levels [24].
In view of this, the second aim of the present research is to evaluate the antidepressive-like activity and
the in vivo antioxidant activity of two GA synthetic derivatives, to verify if some structural changes (i.e.,
increase of lipophilicity) can alter the activities of these GA derivatives. The synthetic analogues, never
tested on any animal model of depression, are M3OMG, previously studied by our research group
regarding its in vivo antioxidant effect and in vitro epigenetic potential, and propyl-3-O-methylgallate,
P3OMG, whose biological activities have not yet been investigated (Figure 1C).
2. Materials and Methods
2.1. Reagents and Materials
Methyl gallate, borax, dimethyl sulphate, dipropyl sulphate, sodium hydroxide, sulphuric acid,
chloroform, sodium chloride and sodium sulphate were purchased from Sigma-Aldrich (St Louis,
MO, USA) for the synthesis of M3OMG and P3OMG. Bovine serum albumin and a kit for protein
measurement were purchased from ZiestChem Company (Tehran, Iran). 5,5-dithiobis(2-nitrobenzoic
acid), ethylenediaminetetraacetic acid, nitro blue tetrazolium chloride, potassium dihydrogen
phosphate, reduced glutathione, sodium dihydrogen phosphate, trichloroacetic acid, thiobarbituric
acid, hydrogen peroxide, sodium carbonate, hydroxylamine chloride, ketamine, lidocaine, xylazine
were purchased from Sigma-Aldrich Chemical Company, (St. Louis, MO, USA). Other chemical
reagents and solvents were of analytical grade or pure and were purchased from Merck Chemical
Company (Darmstadt, Germany).
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2.2. M3OMG and P3OMG Syntheses
The synthesis of M3OMG and P3OMG was performed as reported by Nabavi et al. [9,10]. In
brief, an aliquot of 10 g of methyl gallate was added to a mixture of borax (80 g) and water (800 mL)
undergoing stirring for 30 min. Using a dropping funnel, dimethyl sulphate (30 mL) and dipropyl
sulphate (30 mL) and NaOH (13 g in 50 mL water) were added dropwise from two sides of the reaction
flask over 2.5 h, to synthetize M3OMG and P3OMG, respectively. After leaving the reaction mixtures
to be stirred overnight, concentrated sulphuric acid (50 mL) was added. The mixtures were further
stirred for 1 h and submitted to liquid extraction five times with CHCl3 (1 L). The combined chloroform
extracts were washed with 500 mL of brine (26% NaCl) and dried over anhydrous sodium sulphate.
Removal of the solvent under reduced pressure gave pure M3OMG and P3OMG, which were used for
the in vivo pharmacological tests.
2.3. Animals
Five-week old male balb/c mice weighing 20–25 g, purchased from the Pasteur Institute of Iran,
were used in the study. All mice were kept in the animal room at 24 ˘ 2 ˝C under a 12/12 h light/dark
cycle and 60% ˘ 5% humidity. Food and water were provided ad libitum. All mice were allowed to
acclimatize with the testing room for 24 h prior to behavioral examinations. In this study, behavioral
examination was performed between 10:00 a.m. and 2:00 p.m. The animal experiments were processed
following internationally accepted ethical guidelines for the care of laboratory animals in accordance
with Principles of Laboratory Animals Care (NIH Publication No. 85-23, revised 1996). The ethical
approval number is “81/021, 10 July 2002”.
2.4. Stroke Inducing
For the induction of ischemic stroke, mice were anaesthetized through the intraperitoneal
administration of a mixture of ketamine (60 mg/kg) and xylazine (5 mg/kg). Bilateral common
carotid artery occlusion (BCCAO) was performed as per the standard experimental animal model of
ischemic stroke. In brief, both right and left carotid arteries were selected and clamped for 5 min by
vascular clamps (time of ischemia). Thereafter, the vascular clamps were removed for the next 10 min
(time of reperfusion), and both carotid arteries were subsequently clamped again for 5 min. Finally,
the vascular clamps were removed and blood circulation was allowed to return in both carotid arteries.
The surgical incisions were sutured and anaesthetized with lidocaine solution as a local anesthetic
drug and the area was washed with an antiseptic solution. All mice were transported to an individual
cage, kept at the standard temperature and allowed to recover normal body temperature. Rectal
temperature was checked every day and animals at 37 ˘ 1 ˝C were used in the study. In addition, we
eliminated animals with abnormal behavior, diarrhea or seizures [25].
2.5. GA, M3OMG and P3OMG Administration
Animals were randomly divided into 8 groups of 10 animals each. GA, M3OMG and P3OMG
were intraperitoneally administered in two doses (25 and 50 mg/kg body weight) for a week. After
the last application, depressive-like behaviors of all animals were tested using despair swimming and
tail suspension tests.
2.6. Examination of Stroke-Induced Anhedonia
For the examination of stroke-induced anhedonia, water bottles were removed from animal cages
for a period of 6 h. Thereafter, two bottles were provided to each animal cage. The first bottle was
filled with sucrose solution (2%, % w/v) and the second bottle was filled with water. This test is based
on the evaluation of the volumes of consumed sucrose and water. Total volumes of sucrose solution
and water were recorded over a period of 6 h [26].
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2.7. Despair Swimming Test (DST)
The despair swimming test is one of the most common animal models for the examination of
depressive-like behaviors. In brief, mice were individually placed in an open cylinder (25 cm height
and 10 cm diameter) containing fresh water at 24 ˘ 2 ˝C (19 cm of height). The animals were forced
to swim for a period of 6 min, with times recorded for periods of immobility (the period during
which animals have no horizontal movement, merely keeping their head above the water surface),
climbing (the period of active vertical movement, in which animals try to keep their forelegs above the
water surface) and swimming (the period of horizontal movement in which animals cross the water
surface) [27].
2.8. Tail Suspension Test (TST)
The tail suspension test is another common model for the examination of depressive-like behaviors
in experimental animals. In brief, mice were suspended at a height of 58 cm for a period of 5 min
through the use of adhesive tape attached 1 cm from the tail tip of each animal. The time of immobility,
defined as the amount of time spent motionless during the 5 min test, was recorded [25].
2.9. Anesthesia and Tissue Collection
At the end of the experimental period, the mice were anesthetized by the intraperitoneal
administration of ketamine (60 mg/kg) and xylazine (5 mg/kg) after withholding food for 12 h.
The brain was removed and kept at ´60 ˝C prior to biochemical assessment.
2.10. Preparation of Tissue Homogenate
The whole brain tissue of each animal was homogenized in 100 mM phosphate buffer saline (1:10,
% w/v) containing ethylenediaminetetraacetic acid (1 mM, pH 7.4) and centrifuged (12,000 g, 30 min, 4
˝C). The supernatant was separated and used for biochemical analysis.
2.11. Measurement of Protein Content
The protein content of the homogenates of brain was determined using the Bradford method with
bovine serum albumin as the standard [28].
2.12. Estimation of Lipid Peroxidation
Lipid peroxidation, expressed as thiobarbituric acid-reactive substance (TBARS) formation, was
determined with the method used by Di Lorenzo et al. [26]. Brain tissue homogenates containing 1
mg protein were mixed with trichloroacetic acid (1 mL, 20%) and thiobarbituric acid (2 mL, 0.67%)
and then incubated for 1 h at 100 ˝C. After cooling, the precipitate was removed by centrifugation.
The absorbance of the reaction mixtures was measured at λ = 532 nm using a blank containing all the
reagents with the exception of tissue homogenates.
2.13. Determination of Superoxide Dismutase Activity
Superoxide dismutase (SOD) activity was examined according to the method used by Misra
and Fridovich [29]. The reaction mixtures consisted of sodium carbonate (1 mL, 50 mM), nitroblue
tetrazolium (0.4 mL, 25 µM), and freshly prepared hydroxylamine hydrochloride (0.2 mL, 0.1 mM).
The reaction mixtures were mixed by inversion followed by the addition of clear supernatant of
homogenates of brain tissue (0.1 mL, 1:10, % w/v). The change in absorbance of the reaction mixture
was recorded at λ = 560 nm.
2.14. Determination of Catalase Activity
The enzyme catalase converts hydrogen peroxide into oxygen and water. Catalase activity was
measured using the method described by Nabavi et al. [30]. The tissue homogenates (containing 5 µg
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of protein) were mixed with hydrogen peroxide (2.1 mL, 7.5 mM) and a time scan was performed for
10 min at λ = 240 nm and 25 ˝C. The disappearance of peroxide due to catalase activity was observed.
One unit of catalase activity is defined as the amount of enzyme that reduces 1 µmol of hydrogen
peroxide in a minute.
2.15. Determination of Reduced Glutathione Level
Reduced glutathione (GSH) level was determined with Ellman’s method [31]. Brain tissue
homogenates (720 µL) were double diluted and trichloroacetic acid (5%) was added to precipitate
their protein content. After centrifugation (12,000 ˆ g, 5 min) the supernatant was taken, 5,5-dithiobis
2-nitrobenzoic acid solution (Ellman’s reagent) was added and the absorbance of the reaction mixture
was measured at λ = 417 nm. A standard curve was drawn using known levels of reduced glutathione
solution. Using this standard calibration curve, reduced glutathione levels were calculated for
the homogenates.
2.16. Statistical Analysis
Statistical analysis was carried out with the SPSS statistical software package version 21.0 (SPSS
Inc., Chicago, IL, USA).Results were expressed as means˘ SD, and p < 0.01 was considered statistically
significant. A Shapiro-Wilk W-test was applied to assess the normal distribution of the data. The
statistical significance of the data was assessed by one-way variance analysis. When significant
differences were found, Bonferroni post hoc testing was used to determine the differences between
the groups involved. Possible bivariate correlations between different parameters were analyzed.
Variables were also adjusted for multiple linear regression models in order to evaluate the association
between enzyme activities (SOD and Cat), the marker of lipid peroxidation (TBARS), and the content
of GSH, with each of the registered behavioral parameters.
3. Results and Discussion
In the initial phase of the investigation, M3OMG and P3OMG were synthesized as reported in
the Materials and Methods section [11]. Their purity was estimated at over 95% (See Supplementary
Materials). Then, GA, M3OMG, and P3OMG were studied for their in vivo antidepressant-like and
antioxidant activities. Experimental animals were divided into three major groups: (a) a control group
of healthy mice; (b) a BCCAO group of animals, which underwent bilateral common carotid artery
occlusion (BCCAO); (c) 6 groups treated with GA, M3OMG and P3OMG at two different doses (25
mg/kg and 50 mg/kg). As previously demonstrated [25], bilateral common carotid artery occlusion
caused anhedonia, a representative symptom of acute ischemic stroke. In fact, the results reported in
Figure 2 show that the BCCAO group was characterized by a significant (p < 0.01) increase in water
consumption and a significant (p < 0.01) drop in sucrose solution consumption compared to the normal
group, demonstrating the validity of this animal model in the study of ischemic stroke.













































































Figure 2. Volu e of ater ( ) and sucrose solution (B) consu ption in the stroke-induced anhedonia
odel. ata are sho n as a ean ( L) ˘ S (n = 3); different letters indicate statistically significant
iffere ces (p 0.01) bet ee t e t o gro s.
Intraperitoneal administration of GA, M3OMG and P3OMG significantly (p < 0.01) modified water
and sucrose solution consumption in a dose-dependent manner at both dosages tested, producing
an improvement in the anhedonia state when compared with the BCCAO group (Figure 2A,B,
respectively). The largest improvement in anhedonia was provided by M3OMG at both doses, which
was able to restore normal water consumption at the 50 mg/kg dose. The least active compound was
found to be P3OMG: at the highest dose (50 mg/kg) it showed the same activity (p = 0.033) on water
consumption as M3OMG administered at the lowest dose (25 mg/kg).
The BCCAO animal model is also a suitable system to study depressive-like behavior through the
use of two validated and commonly used tests, the despair swimming test (DST) and the tail suspension
test (TST). DST is an important model of depressive-like behavior in which animals are forced to
swim in a cylindrical container filled with water. Climbing, swimming and immobility periods are
registered for the 6 min duration of the test [25]. At both concentrations and in a dose-dependent
manner, the tested compounds showed antidepressive-like activity, significantly (p < 0.01) increasing
the climbing and swimming times and decreasing the immobility time with respect to the BCCAO
group (Figures 3–5 respectively).













































































Figure 3. Effects of intraperitoneal administration of GA, M3OMG and P3OMG on climbing time in
the despair swimming test. Data are a mean (s) ˘ SD (n = 7); different letters indicate statistically













































































Figure 4. Effects of intraperitoneal administration of GA, M3OMG and P3OMG on swimming time
in the despair swimming test. Data are a mean (s) ˘ SD (n = 7); different letters indicate statistically









TST describes  the depressive behavior of experimental animals  through  the determination of 
immobility time in unavoidable and inescapable stress conditions. An antidepressant agent reduces 
the immobility times for unsuccessful attempts to escape [32]. For both concentrations and in a dose‐




Figure  6.  Effects  of  the  intraperitoneal  administration  of GA, M3OMG  and  P3OMG  on  the  tail 
suspension model. Data are a mean (s) ± SD (n = 7); different letters indicate statistically significant 
differences (p < 0.01) between the two groups. 
In our previous  review, we  reported  that  there  is a growing body of evidence  that supports 
oxidative stress as playing a fundamental role in the pathogenesis of both ischemic stroke and major 
depression.  Thus,  we  formulated  the  hypothesis  that  oxidative  stress  is  also  involved  in  the 
pathogenesis  of  post‐stroke  depression,  and  antioxidant  substances  could  thus  be  useful  in  the 
treatment of this pathology [18]. Considering the in vitro and in vivo antioxidant and neuroprotective 
effects of GA and its related compounds, which are well documented in the literature [19,33–36], the 
present study was extended  to  the evaluation of  the  in vivo protective effect of GA, M3OMG and 





completely  restore  normal  conditions  (Figure  7A). Among  the  tested  compounds, M3OMG was 
found to be the most active at both dosages (25 and 50 mg/kg), whilst P3OMG was less active. In fact, 
at  the highest dose P3OMG showed  the same activity  (p = 0.196) as M3OMG administered at  the 
lowest  concentration. As  far as endogenous antioxidant defenses are  concerned,  the  induction of 
stroke was found to cause a significant (p < 0.01) decrease in SOD and Cat activities and GSH levels 
Figure 5. Effects of intraperitoneal ad inistration of , 3 and P3 on i obility ti e
in the despair s i ing test. Data are a ean (s) ˘ SD (n = 7); different letters indicate statistically
significant differences (p < 0.01) between the two groups.
r ll t r t rs r ist r t t s s, t st cti c s f t
, ilst t e le st cti e s , ic ere t s s t e s e cti it (p ě . ) t t e
i est s e ( kg) as M3OMG administered at the lowest dosage (25 g/kg).
scri s t r ssi i r f ri t l i ls t r t t r i ti f
i ilit ti e i i le i esc le stress c iti s. ti e ress t e t re ces
t e immobility times for unsuccessful attempts to escape [32]. For both conce tr tions and in
a dose-depende t manner, GA, 3OMG and P3OMG showed high antidepressive-like activity,
si ific tl (p < 0.01) decreasing the i mobility time of the treated mice compared with that of
the BCCAO group (Figure 6). Here too, M3OMG results as the most active compound at both doses.
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suspension model. Data are a mean (s) ˘ SD (n = 7); different letters indicate statistically significant
differences (p < 0.01) between the two groups.
In o r revio s revie , e re orte that there is a gro ing bo y of evi ence that s orts
oxi ative stress as playing a fundamental role in the pathogenesis of both ischemic stroke and
major depression. Thus, we formulated the hypothesis that oxidative stress is also involved in
the pathogenesis of post-stroke depression, and antioxidant substances could thus be useful in t e
treat e t of t is at ology [18]. o si eri g t e in vitro a in vivo a tioxi a t a e ro rotective
effects of GA and its related compounds, which are well documented in the literature [19,33–36],
the present study was extended to the evaluation of the in vivo protective effect of GA, 3OMG
and P3OMG against oxidative stress. The antioxidant activities of SOD and Cat, the degree of li i
eroxi atio , (ex resse i S le els), a S le els ere eter i e for o se brai s. s
ex ecte , stro e i ce a si ifica t (p 0.01) i crease i S le els, re eali i oxi ati e
stress i t e r . e treat e t it , 3 a 3 si ifica tl (p 0.01)
ecrease RS levels at both tested concentrations, even though the compounds were not able
t completely restore normal conditions (Figure 7A). Among the tested co pounds, 3 as
f to be the most active at both dosages (25 and 50 mg/kg), whilst P3OMG was less active. In
fact, at the highest dose P3OMG showed the same activity (p = 0.196) as M3OMG administered at
the lowest concentration. As far as endogenous antioxidant defenses are concerned, the inducti n
of stroke was found to cause a significant (p < 0.01) decrease in SOD and Cat activities and GSH
levels in comparison with the control group, confirming a relevant oxidative stress condition in the
BCCAO group. Although the administration of GA, M3OMG and P3OMG improved endogenous
antioxidant defenses, increasing SOD and Cat activities and GSH levels compared to the BCCAO
group, the registered values did not attain those determined in the normal group (Figure 7B–D,
respectively). M3OMG again exerted the highest antioxidant activity at both dosages, compared to
GA and P3OMG, resulting as the most promising antioxidant compound with potential uses in the
treatment of post-stroke depression.
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To explore the relationship between the results obtained from behavioral tests and antioxidant
assays in more depth, we evaluated possible bivariate correlations between the independent variables,
consisting of enzyme activities (SOD and Cat), the marker of lipid peroxidation (TBARS), and the
content of GSH, with the registered behavioral parameters taken as dependent variables (Table 1).
Statistical significance was found for the associations of GSH, SOD and TBARS, with all the dependent
variables. The highest significant associations were found between SOD and the dependent climbing
and swimming variables, and for GSH and TBARS with immobility and immobility registered in
TST. There were no significant associations between Cat activity and any of the studied behavioral
parameters. These results support the hypothesis that oxidative stress is closely related and tightly
linked to post-stroke depression.
Table 1. Multiple linear regression analysis on the dependent variables of climbing, swimming,





Climbing Swimming Immobility Immobility(TST)
Cat
β 0.586 0.256 ´1.961 ´1.730
p 0.190 0.285 0.178 0.292
GSH
β ´7.125 ´3.241 28.265 27.411
p 0.000 0.000 0.000 0.000
SOD
β 0.340 0.135 ´1.149 ´1.220
p 0.004 0.029 0.003 0.005
TBARS
β ´1.098 ´0.646 4.210 5.045
p 0.037 0.023 0.015 0.010
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4. Conclusions
In this study we have demonstrated that the intraperitoneal administration of GA, M3OMG and
P3OMG restores behavioral parameters indicative of depression to healthy levels in experimental
animals in which PSD has been induced by bilateral common carotid artery occlusion. M3OMG was
found to be more active than GA and P3OMG, decreasing anhedonia and improving depressive-like
behavior. In all behavioral tests, GA was found to be less effective than M3OMG at both doses,
and P3OMG administered at the highest dose (50 mg/kg) showed the same activity as M3OMG
administered at the lowest dose (25 mg/kg). These data suggest that increasing lipophilicity, moving
from GA to M3OMG, increases the antidepressive-like activity while a further increase of lipophilicity,
moving from M3OMG to the propyl derivative, does not correspond to an increase in activity.
The in vivo antioxidant activity exerted by GA, M3OMG and P3OMG supports the hypothesis that
oxidative stress, which occurs during cerebral ischemia and the following reperfusion, is implicated
in the pathogenesis of PSD. M3OMG shows the highest capacity to improve SOD and Cat activities,
GSH levels and decrease TBARS levels, which confirms that this compound shows higher activity
than GA and P3OMG. The relationship found between the results obtained from behavioral tests
and antioxidant assays corroborates our hypothesis that oxidative stress is closely related and tightly
linked to stroke and post-stroke depression. It is very interesting to highlight that bivariate correlations
were shown for associations between GSH, SOD and TBARS, and all behavioral parameters, while
no significant associations between Cat activity and any behavioral parameters were found. These
last results seems to suggest that the capacity of these exogenous antioxidant compounds to modulate
depressive symptoms is probably exerted primarily through SOD activity, GSH levels and a decrease
in lipid peroxidation instead of through Cat activity.
Though GA and its derivatives were administered through intraperitoneal injection rather than
oral ingestion, the obtained results are interesting because they show a new biological function of these
hydroxy-benzoic compounds. Future studies will be performed using the oral route of administration
in view of a future use for these compounds in food supplements or drugs, and to mimic the ingestion
of these polyphenols as part of plant based foods and beverages. In conclusion, this work represents
the first attempt to demonstrate the positive effect of GA and its synthetic derivatives on post-stroke
depression and to correlate this protective activity with their antioxidant activity.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/5/248/s1.
Acknowledgments: Antoni Sureda was supported by Spanish Ministry of Health and Consumer Affairs
(CIBEROBN CB12/03/30038). We thank the EPSRC National Mass Spectrometry Facility (Singleton Park, Swansea,
UK) for acquiring the MS data.
Author Contributions: Seyed Mohammad Nabavi, Solomon Habtemariam and Maria Daglia designed the paper,
Maria Daglia collected and selected the literature data, Antoni Sureda and Seyed Fazel Nabavi analyzed the
data, Arianna Di Lorenzo, Sedigheh Khanjani, Maria Daglia and Seyed Mohammad Nabavi wrote the paper. All
authors participated in the analysis and interpretation of literature data, revised the paper and approved the
final manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Herrmann, K.M.; Weaver, L.M. The shikimate pathway. Ann. Rev. Plant Biol. 1999, 50, 473–503. [CrossRef]
[PubMed]
2. Nabavi, S.F.; Nabavi, S.M.; Habtemariam, S.; Moghaddam, A.H.; Sureda, A.; Jafari, M.; Latifi, A.M.
Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced
oxidative stress. Ind. Crops Prod. 2013, 44, 50–55. [CrossRef]
3. Kim, S.H.; Jun, C.D.; Suk, K.; Choi, B.J.; Lim, H.; Park, S.; Lee, S.H.; Shin, H.Y.; Kim, D.K.; Shin, T.Y. Gallic
acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 2006, 91,
123–131. [CrossRef] [PubMed]
Nutrients 2016, 8, 248 12 of 13
4. Daglia, M.; Di Lorenzo, A.; Nabavi, S.F.; Talas, Z.S.; Nabavi, S.M. Polyphenols: Well beyond the antioxidant
capacity: Gallic acid and related compounds as neuroprotective agents: You are what you eat! Curr. Pharm.
Biotechnol. 2014, 15, 362–372. [CrossRef] [PubMed]
5. Kaur, M.; Velmurugan, B.; Rajamanickam, S.; Agarwal, R.; Agarwal, C. Gallic acid, an active constituent of
grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate
carcinoma xenograft growth in nude mice. Pharm. Res. 2009, 26, 2133–2140. [CrossRef]
6. Nabavi, S.M.; Habtemariam, S.; Nabavi, S.F.; Sureda, A.; Daglia, M.; Moghaddam, A.H.; Amani, M.A.
Protective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative
stress in rat’s kidney. Mol. Cell. Biochem. 2013, 372, 233–239. [CrossRef]
7. Shao, D.; Li, J.; Li, J.; Tang, R.; Liu, L.; Shi, J.; Huang, Q.; Yang, H. Inhibition of gallic acid on the growth and
biofilm formation of Escherichia coli and Streptococcus mutans. J. Food Sci. 2015, 80, M1299–M1305. [CrossRef]
[PubMed]
8. Habtemariam, S. Methyl-3-O-methyl gallate and gallic acid from the leaves of Peltiphyllum peltatum: isolation
and comparative antioxidant, prooxidant, and cytotoxic effects in neuronal cells. J. Med. Food 2011, 14,
1412–1418. [CrossRef]
9. Nabavi, S.F.; Nabavi, S.M.; Habtemariam, S.; Moghaddam, A.H.; Sureda, A.; Mirzaei, M. Neuroprotective
effects of methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in the brain of rats.
Cell. Mol. Neurobiol. 2013, 33, 261–267. [CrossRef]
10. Nabavi, S.M.; Habtemariam, S.; Nabavi, S.F.; Moghaddam, A.H.; Latifi, A.M. Prophylactic effects of
methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in erythrocytes in vivo. J.
Pharm. Pharmacol. 2013, 65, 868–873. [CrossRef] [PubMed]
11. Curti, V.; Capelli, E.; Boschi, F.; Nabavi, S.F.; Bongiorno, A.I.; Habtemariam, S.; Nabavi, S.M.; Daglia, M.
Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo
protective activities. Mol. Nutr. Food Res. 2014, 58, 1776–1784. [CrossRef] [PubMed]
12. Civenni, G.; Iodice, M.; Nabavi, S.F.; Habtemariam, S.; Nabavi, S.M.; Catapano, C.; Daglia, M. Gallic acid
and methyl-3-O-methyl gallate: A comparative study on their effects on prostate cancer stem cells. RSC Adv.
2015, 5, 63800–63806. [CrossRef]
13. Roger, V.L.; Go, A.S.; Lloyd-Jones, D.M.; Benjamin, E.J.; Berry, J.D.; Borden, W.B.; Bravata, D.M.; Dai, S.;
Ford, E.S.; Fox, C.S.; et al. Heart disease and stroke statistics—2012 update a report from the American heart
association. Circulation 2012, 125, e2–e220.
14. Bolaños, J.P.; Moro, M.A.; Lizasoain, I.; Almeida, A. Mitochondria and reactive oxygen and nitrogen species
in neurological disorders and stroke: Therapeutic implications. Adv. Drug Deliv. Rev. 2009, 61, 1299–1315.
[CrossRef] [PubMed]
15. Yang, Y.; Rosenberg, G.A. Blood–brain barrier breakdown in acute and chronic cerebrovascular disease.
Stroke 2011, 42, 3323–3328. [CrossRef] [PubMed]
16. Loubinoux, I.; Kronenberg, G.; Endres, M.; Schumann-Bard, P.; Freret, T.; Filipkowski, R.K.; Kaczmarek, L.;
Popa-Wagner, A. Post-stroke depression: Mechanisms, translation and therapy. J. Cell. Mol. Med. 2012, 16,
1961–1969. [CrossRef] [PubMed]
17. World Health Organization WH. In Promoting Fruit and Vegetable Consumption around the World; World Health
Organization: Geneva, Switzerland, 2010.
18. Nabavi, S.F.; Dean, O.M.; Turner, A.; Sureda, A.; Daglia, M.; Nabavi, S.M. Oxidative stress and post-stroke
depression: Possible therapeutic role of polyphenols? Curr. Med. Chem. 2015, 22, 343–351. [CrossRef]
19. Nabavi, S.F.; Habtemariam, S.; Jafari, M.; Sureda, A.; Nabavi, S.M. Protective role of gallic acid on sodium
fluoride induced oxidative stress in rat brain. Bull. Environ. Contam. Toxicol. 2012, 89, 73–77. [CrossRef]
[PubMed]
20. Nabavi, S.F.; Habtemariam, S.; Sureda, A.; Moghaddam, A.H.; Daglia, M.; Nabavi, S.M. In vivo protective
effects of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress in
rat erythrocytes. Arch. Ind. Hygiene Toxicol. 2013, 64, 553–559. [CrossRef]
21. Sarkaki, A.; Fathimoghaddam, H.; Mansouri, S.; Korrani, M.S.; Saki, G.; Farbood, Y. Gallic acid improves
cognitive, hippocampal long-term potentiation deficits and brain damage induced by chronic cerebral
hypoperfusion in rats. Pak. J. Biol. Sci. 2014, 17, 978.
22. Chhillar, R.; Dhingra, D. Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic
mild stress. Fundam. Clin. Pharmacol. 2013, 27, 409–418. [CrossRef] [PubMed]
Nutrients 2016, 8, 248 13 of 13
23. Nagpal, K.; Singh, S.K.; Mishra, D.N. Nanoparticle mediated brain targeted delivery of gallic acid: In vivo
behavioral and biochemical studies for improved antioxidant and antidepressant-like activity. Drug Deliv.
2012, 19, 378–391. [CrossRef] [PubMed]
24. Azzolini, M.; Mattarei, A.; La Spina, M.; Marotta, E.; Zoratti, M.; Paradisi, C.; Biasutto, L. Synthesis and
evaluation as prodrugs of hydrophilic carbamate ester analogues of resveratrol. Mol. Pharm. 2015, 12,
3441–3454. [CrossRef]
25. Nabavi, S.F.; Sobarzo-Sanchez, E.; Nabavi, S.M.; Daglia, M.; Moghaddam, A.H.; Silva, A.G. Behavioral effects
of 2,3-dihydro-and oxoisoaporphine derivatives in post stroke-depressive like behavior in male balb/c mice.
Curr. Top. Med. Chem. 2013, 13, 2127–2133. [CrossRef]
26. Di Lorenzo, A.; Nabavi, S.F.; Sureda, A.; Moghaddam, A.H.; Khanjani, S.; Arcidiaco, P.; Nabavi, S.M.;
Daglia, M. Antidepressive-like effects and antioxidant activity of green tea and GABA green tea in a mouse
model of post-stroke depression. Mol. Nutr. Food Res. 2015. [CrossRef]
27. Moghaddam, A.H.; Sobarzo-Sánchez, E.; Nabavi, S.F.; Daglia, M.; Nabavi, S.M. Evaluation of the
antipsychotic effects of 2-(dimethylamino)-and 2-(methylamino)-7H-naphtho [1,2,3-de] quinolin-7-one
derivatives in experimental model of psychosis in mice. Curr. Top. Med. Chem. 2014, 14, 229–233. [CrossRef]
28. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein
utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [CrossRef]
29. Misra, H.P.; Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay
for superoxide dismutase. J. Biol. Chem. 1972, 247, 3170–3175.
30. Nabavi, S.M.; Nabavi, S.F.; Eslami, S.; Moghaddam, A.H. In vivo protective effects of quercetin against
sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem. 2012, 132, 931–935. [CrossRef]
31. Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70–77. [CrossRef]
32. Castagné, V.; Moser, P.; Roux, S.; Porsolt, R.D. Rodent models of depression: Forced swim and tail suspension
behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. 2011, 55, 11–18. [CrossRef]
33. Mansouri, M.T.; Farbood, Y.; Sameri, M.J.; Sarkaki, A.; Naghizadeh, B.; Rafeirad, M. Neuroprotective effects
of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 2013, 138,
1028–1033. [CrossRef] [PubMed]
34. Sun, J.; Li, Y.Z.; Ding, Y.H.; Wang, J.; Geng, J.; Yang, H.; Ren, J.; Tang, J.Y.; Gao, J. Neuroprotective effects
of gallic acid against hypoxia/reoxygenation-induced mitochondrial dysfunctions in vitro and cerebral
ischemia/reperfusion injury in vivo. Brain Res. 2014, 1589, 126–139. [CrossRef] [PubMed]
35. Ban, J.Y.; Nguyen, H.T.T.; Lee, H.J.; Cho, S.O.; Ju, H.S.; Kim, J.Y.; Bae, K.; Song, K.S.; Seong, Y.H.
Neuroprotective properties of gallic acid from Sanguisorbae Radix on amyloid. BETA. Protein (25–35)-induced
toxicity in cultured rat cortical neurons. Biol. Pharm. Bull. 2008, 31, 149–153. [CrossRef] [PubMed]
36. Korani, M.S.; Farbood, Y.; Sarkaki, A.; Moghaddam, H.F.; Mansouri, M.T. Protective effects of gallic acid
against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats. Eur. J.
Pharmacol. 2014, 733, 62–67. [CrossRef]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
